Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Please NOTE for patients paying cash, a superbill will be provided for insurance reimbursement
PMC 10773707
As a dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and weight management, tirzepatide acts on receptors throughout the central nervous system, influencing appetite regulation and potentially offering neuroprotective properties
It may also increase the risk of low blood sugar when used with other diabetes medications
If you added 2mL instead of 3mL to a 15mg vial, your concentration is 7.5mg/mL instead of 5mg/mLmeaning each 0.1mL draw now contains 750mcg instead of 500mcg
Both are measurable on a standard insulin syringe
US$ 20.15
US$ 29.15
US$ 23.56
US$ 25.41
US$ 29.52
